Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-11

Clinical Trial Update: A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076 [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial evaluating the safety and effectiveness of solifenacin solution for symptoms of overactive bladder in children/adolescents; the study (9…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solifenacin solution (solifenacin)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Urinary Bladder, Overactive | Phase 3 | Status: COMPLETED | Results posted: 2017-12-11